Inside the Lab Industry: Q2 Earnings Decline Despite Rebound in Core Business
Though COVID-19 testing declines continue to negatively affect lab industry profits, the latest figures suggest the worst may be over.
Earnings-lir
Subscribe today for access to
Articles and Reports
Inside the Lab Industry: COVID-19 Declines Kill Top Lab Company Earnings but Genetic Firms Rebound
Yet, despite these declines, Q1 was neither as bad as expected nor totally devoid of positive signs for the future.
COVID-19 Losses Take a Toll on Q4 Earnings—but It Could Have Been Worse
Though Q4 earnings in the lab industry took a beating as predicted, the earnings picture wasn’t nearly as bleak as many had feared.
DX Earnings Report: Lab Companies Finish 2018 Strong but Growth Slows for Established Firms
From - Laboratory Industry Report
The diagnostics industry capped a robust 2018 with most companies posting strong fourth quarter results. Of course…
Market Trends: Lab-Retail Collaboration Remains Strong Despite Theranos Debacle
From - Laboratory Industry Report
The Theranos debacle hasn't dissuaded retailers from partnering with labs…
Earnings Report: Top Payers Announce Q3 Earnings
From - Laboratory Industry Report
The country's five largest commercial payers posted strong results for the third quarter of fiscal year 2018…
Lab Leaders Have New Opportunities in the Age of Consumerism
From - Laboratory Industry Report
The G2 Power Panel provided attendees at the 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) an opportunity to learn how some of…
DX Earnings Report: Q2 Lab Earnings Stay Strong but Not Quite at Q1 Levels
...
Already a member? Log in here
Cost Avoidance vs Cost Savings: What’s the Difference?
By Jennifer Dawson, MHA, DLM (ASCP) bio
As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to demonstrate…
How to Avoid a Laboratory Audit
By Sean McSweeney bio
Laboratory audits have a much harder impact on your lab than intended. As detailed by the NCBI, the audit's intent is to review and…
PAMA Unlocks Golden Age for Innovative Diagnostics
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings
From - Laboratory Industry Report
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs…
Dx Earnings Report: Strong Q4 as Lab Companies End Year with a Bang
From - Laboratory Industry Report
Big PAMA cuts may lay ahead in 2017, but the diagnostics industry had a robust 2017. While the entire year was strong, success was…
